Tower Research Capital LLC (TRC) - SILVERBACK THERAPEUTICS INC ownership

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of SILVERBACK THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$134,742
+111.6%
35,646
+275.1%
0.00%
+100.0%
Q2 2023$63,670
+99384.4%
9,503
-2.0%
0.00%0.0%
Q1 2023$64
-8.6%
9,701
+18.9%
0.00%
-33.3%
Q4 2022$70
-99.8%
8,162
+23.3%
0.00%
+200.0%
Q3 2022$35,000
-22.2%
6,620
-37.3%
0.00%0.0%
Q2 2022$45,000
-35.7%
10,559
-46.7%
0.00%0.0%
Q1 2022$70,000
+268.4%
19,803
+608.8%
0.00%
Q4 2021$19,000
-58.7%
2,794
-38.9%
0.00%
-100.0%
Q3 2021$46,000
+35.3%
4,574
+317.3%
0.00%0.0%
Q2 2021$34,000
+17.2%
1,096
+66.8%
0.00%
Q1 2021$29,0006570.00%
Other shareholders
SILVERBACK THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Orbimed Advisors 8,740,887$87,234,0000.96%
Boxer Capital, LLC 1,675,377$16,720,0000.58%
EcoR1 Capital, LLC 1,184,710$11,823,0000.41%
Nantahala Capital Management 1,226,631$12,242,0000.39%
5AM Venture Management, LLC 169,748$1,694,0000.34%
COMMODORE CAPITAL LP 97,143$969,0000.26%
RA Capital Management 1,742,186$17,387,0000.24%
HighVista Strategies LLC 22,434$224,0000.15%
Rhenman & Partners Asset Management AB 150,000$1,497,0000.10%
Woodline Partners LP 425,261$4,244,0000.07%
View complete list of SILVERBACK THERAPEUTICS INC shareholders